[Pharmacological support in dental treatment of hemophiliac patients].
The hemophilic syndrome (hemophilia A, B, C) represent about the 90-95% of all the congenital coagulopathy; in order to avoid immediate or belated hemorrhagic complications it is necessary to give these patients all the care they need. When the hemophiliacs have to be submitted to oral surgery operations we can use various therapies according to the seriousness and to the type of the disease. We have also taken into consideration the ways to grant a local hemostatic control.
Tonelli
P
P
Università degli Studi di Firenze.
Bruni
F
F
Massi
B
B
Amunni
F
F
D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use*; D003730:Dental Care for Persons with Disabilities; D006489:Hemostatic Techniques; D006801:Humans; D014081:Tooth Extraction; D014662:Vasoconstrictor Agents
D014662:Vasoconstrictor Agents; D003894:Deamino Arginine Vasopressin
Il supporto farmacologico nel trattamento odontoiatrico dei pazienti emofilici.